Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
International Flavors & Fragrances logo

International Flavors & Fragrances Business Segments

Business, geographic, and product segment breakdowns

International Flavors & Fragrances generates $10.8B in annual revenue across 4 key segments: Food Ingredients ($12.2B), Health & Biosciences ($595.0M), Scent ($651.0M), and Taste ($656.0M). The company-wide operating margin is -1.91%. Based on the Q1 2026 filing.

Food Ingredients (TTM)$12.2BHealth & Biosciences$595.0MScent$651.0MTaste$656.0M
Latest FilingQ1 2026
Report Date2026-05-05
Market Cap$19.8B
P/E Ratio24.10
ROE6.02%

Geographic

Net Sales

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Europe, Africa and Middle East$2.8B$2.8B$2.8B$2.7B$2.6B$2.7B
Greater Asia$2.8B$2.8B$2.8B$2.7B$2.6B$2.7B
Latin America$2.8B$2.8B$2.8B$2.7B$2.6B$2.7B
Net sales attributed to all foreign countries$2.8B$2.8B$2.8B$2.7B$2.6B$2.7B
North America$2.8B$2.8B$2.8B$2.7B$2.6B$2.7B

Concentration risk threshold

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Foreign Countries0.030.030.030.030.03—

Property, plant and equipment

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
United States$3.7B$3.8B$3.9B$3.9B$4B$4B

Maximum percentage of total consolidated net sales attributed to any non-U.S. country

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net sales attributed to all foreign countries—0.100.100.10—0.10

Business Segments

Adjusted Operating EBITDA

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences—$138M$151M$150M—$153M
Taste$87M$131M$125M$128M$94M$153M
Scent$106M$144M$130M$135M$106M$148M
Food Ingredients$100M$111M$124M$106M$82M$114M

Restructuring, expected cost

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients And Taste Segments————$130M—

Capital Expenditures

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences$160M$179M$95M$132M$188M$165M
Pharma Solutions$160M$179M$95M$132M$188M$165M
Scent$160M$179M$95M$132M$188M$165M
Food Ingredients$62M$60M$40M$59M$64M$50M
Taste$28M$27M$15M$15M$42M$24M

Cost of Sales

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients$1.8B$1.8B$1.7B$1.7B$1.7B$1.7B
Health & Biosciences$1.8B$1.8B$1.7B$1.7B$1.7B$1.7B
Scent$1.8B$1.8B$1.7B$1.7B$1.7B$1.7B
Taste$1.8B$1.8B$1.7B$1.7B$1.7B$1.7B

Depreciation Expense, Add-Back

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients-$32M$28M$34M$35M-$227M$34M
Health & Biosciences-$29M-$29M-$31M-$32M-$32M-$32M
Scent-$17M$15M$17M$17M-$116M$18M
Taste-$18M-$15M-$16M-$16M-$18M-$16M

Goodwill

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients$9.1B$8B$8.3B$8.3B$8.3B$8.2B
Health & Biosciences$9.1B$8B$8.3B$8.3B$8.3B$8.2B
Scent$9.1B$8B$8.3B$8.3B$8.3B$8.2B
Taste$9.1B$8B$8.3B$8.3B$8.3B$8.2B

Goodwill, accumulated impairment loss

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients$4.9B———$6B—
Health & Biosciences$4.9B———$6B—

Goodwill, Written off Related to Sale of Business Unit

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients$0$0$0$0$0—
Health & Biosciences$0$0$0$0$0—
Nourish$2.5M$0$0$0$0—
Pharma Solutions$0$0$0$0$0—
Scent$0$0$0$0$0—
Taste$0$2M$2M$2M$2M—

Net Sales

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients$2.8B$2.8B$2.8B$2.7B$2.6B$2.7B
Health & Biosciences$2.8B$2.8B$2.8B$2.7B$2.6B$2.7B
Scent$2.8B$2.8B$2.8B$2.7B$2.6B$2.7B
Taste$2.8B$2.8B$2.8B$2.7B$2.6B$2.7B

Research and development expenses

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients$170M$164M$182M$174M$174M$166M
Health & Biosciences$170M$164M$182M$174M$174M$166M
Scent$170M$164M$182M$174M$174M$166M
Taste$170M$164M$182M$174M$174M$166M

Restructuring Charges

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients$23M$17M$21M$16M$16M$6M
Health & Biosciences$23M$17M$21M$16M$16M$6M
Scent$23M$17M$21M$16M$16M$6M
Taste$23M$17M$21M$16M$16M$6M

Selling and administrative expenses

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Food Ingredients$517M$461M$483M$421M$469M$427M
Health & Biosciences$517M$461M$483M$421M$469M$427M
Scent$517M$461M$483M$421M$469M$427M
Taste$517M$461M$483M$421M$469M$427M

Additional charges, net

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences$23M$17M$21M$16M$16M$6M

Cost of Product and Service Sold

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences$1.8B$1.8B$1.7B$1.7B$1.7B$1.7B

Foreign exchange

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences-$116M$60M$126M$0$5M-$22M
Taste—$39M$94M$0$9M-$20M
Scent-$29M$14M$32M——-$7M

Segment Adjusted Operating EBITDA

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health & Biosciences$136M$138M$151M$150M$155M$153M